Literature DB >> 17905404

Cone-specific expression using a human red opsin promoter in recombinant AAV.

Qiuhong Li1, Adrian M Timmers, John Guy, Jijing Pang, William W Hauswirth.   

Abstract

PURPOSE: To determine the feasibility of targeting gene expression specifically to cone photoreceptors using recombinant adeno-associated virus (rAAV) as the vector.
METHODS: An rAAV vector was constructed that contains a 2.1kb upstream sequence of the human red opsin gene to direct green fluorescent protein (GFP) expression. A control construct containing a 472bp mouse rod opsin promoter, previously shown to drive photoreceptor-specific expression, was also used. Each recombinant virus was injected into the subretinal space of rat, ferret or guinea pig eyes. GFP expression was analyzed 4-6 weeks after injection microscopically. RESULT: The human 2.1kb cone opsin gene upstream sequence targeted GFP expression only to a subset of photoreceptors. Cone-specific expression was shown by co-localization of GFP fluorescence and cone-specific opsin antibody staining. Additionally, in rats, expression was specific for L/M-cones whereas no S-cones exhibited GFP fluorescence. The efficiency of rAAV mediated cone transduction surrounding the injection site was high since every L/M-cone antibody-staining cone was also positive for GFP expression.
CONCLUSION: The human red/green opsin gene promoter used in this study is sufficient to direct efficient cone-specific gene expression in several mammalian species, suggesting that key cell-type specific regulatory elements must be broadly conserved in mammals. These observations have significance in devising gene therapy strategies for retinal dystrophies that primarily affect cones and point toward a way to functionally dissect the cone opsin promoter in vivo.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17905404     DOI: 10.1016/j.visres.2007.07.026

Source DB:  PubMed          Journal:  Vision Res        ISSN: 0042-6989            Impact factor:   1.886


  30 in total

Review 1.  AAV and compacted DNA nanoparticles for the treatment of retinal disorders: challenges and future prospects.

Authors:  Zongchao Han; Shannon M Conley; Muna I Naash
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-05-10       Impact factor: 4.799

2.  Mechanistic basis for the failure of cone transducin to translocate: why cones are never blinded by light.

Authors:  Ekaterina S Lobanova; Rolf Herrmann; Stella Finkelstein; Boris Reidel; Nikolai P Skiba; Wen-Tao Deng; Rebecca Jo; Ellen R Weiss; William W Hauswirth; Vadim Y Arshavsky
Journal:  J Neurosci       Date:  2010-05-19       Impact factor: 6.167

Review 3.  Curing color blindness--mice and nonhuman primates.

Authors:  Maureen Neitz; Jay Neitz
Journal:  Cold Spring Harb Perspect Med       Date:  2014-08-21       Impact factor: 6.915

4.  Gene therapy prevents photoreceptor death and preserves retinal function in a Bardet-Biedl syndrome mouse model.

Authors:  David L Simons; Sanford L Boye; William W Hauswirth; Samuel M Wu
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-28       Impact factor: 11.205

5.  The effect of hypothyroidism on color contrast sensitivity: a prospective study.

Authors:  Mehtap Cakir; Banu Turgut Ozturk; Elif Turan; Gulsum Gonulalan; Ilker Polat; Kemal Gunduz
Journal:  Eur Thyroid J       Date:  2015-02-07

6.  Gene therapy for red-green colour blindness in adult primates.

Authors:  Katherine Mancuso; William W Hauswirth; Qiuhong Li; Thomas B Connor; James A Kuchenbecker; Matthew C Mauck; Jay Neitz; Maureen Neitz
Journal:  Nature       Date:  2009-09-16       Impact factor: 49.962

7.  rAAV2/5 gene-targeting to rods:dose-dependent efficiency and complications associated with different promoters.

Authors:  W A Beltran; S L Boye; S E Boye; V A Chiodo; A S Lewin; W W Hauswirth; G D Aguirre
Journal:  Gene Ther       Date:  2010-04-29       Impact factor: 5.250

Review 8.  The use of canine models of inherited retinal degeneration to test novel therapeutic approaches.

Authors:  William A Beltran
Journal:  Vet Ophthalmol       Date:  2009 May-Jun       Impact factor: 1.644

9.  Longitudinal evaluation of expression of virally delivered transgenes in gerbil cone photoreceptors.

Authors:  Matthew C Mauck; Katherine Mancuso; James A Kuchenbecker; Thomas B Connor; William W Hauswirth; Jay Neitz; Maureen Neitz
Journal:  Vis Neurosci       Date:  2008 May-Jun       Impact factor: 3.241

10.  Targeting gene expression to cones with human cone opsin promoters in recombinant AAV.

Authors:  A M Komáromy; J J Alexander; A E Cooper; V A Chiodo; L G Glushakova; G M Acland; W W Hauswirth; G D Aguirre
Journal:  Gene Ther       Date:  2008-03-13       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.